Cite Filings / KYMR / 0001628280-26-044732
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Kymera Therapeutics, Inc. · Filed 2026-06-22 · Acc 0001628280-26-044732

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-06-23 144 Sale of Securities
  • 2026-06-22 144 Sale of Securities
  • 2026-06-22 144 Sale of Securities
  • 2026-06-22 144 Sale of Securities
  • 2026-06-22 4 Director sold 31,798 shares at an average $103.75 ($3,299,037)
  • 2026-06-22 4 Director sold 478,198 shares at an average $94.72 ($45,293,294)
  • 2026-06-22 4 Chief Business Officer sold 2,500 shares at $99.00 ($247,500)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…